https://seekingalpha.com/article/4354772-endra-lif
Post# of 148322
(Total Views: 921)
Posted On: 06/22/2020 5:37:45 PM
Re: LaundryMoney #38546
https://seekingalpha.com/article/4354772-endr...tion-point
That article isn’t exactly about Cytodyn but we were mentioned as a Possible therapy for NASH. Remember when Nader said our animal testing were twice as good as another company’s animal trial and they received a 100 million licensing deal on a phase 1/2 animal trial. We somehow missed our possible licensing deal on NASH. But we took a different path lately for Covid-19.
After reading that alpha article. Just look at the numbers that do have NAFLD. It's 1 billion people. For Nash numbers...Take 2% of that 1 billion = 20 million x $60,000 annual therapy= 1.2 trillion dollars which would have a stock price of around $1,500/share approx. that’s only at 2% and that is even a conservative number when the estimate is between 3-12% have Nash of that one billion NAFLD. So it could be even more or still have some market share if other drugs prove to be good also. Will there ever be a ceiling on stock price for this drug???
Then look at the Tedx and the Beckham videos this past week for more second party scientific information being released. Also, Ted talks has their own cable channel in some countries. Doesn’t seem to have a ton of views in YouTube yet but I know Canada has Ted talks on their cable tv. It would appear that word is getting out without Cytodyn having to advertise. I do miss a weekly conference call. I hope we still have some kind of communication with Nader weekly or monthly. Being in the loop is a good thing.
We are going to continue to climb In SP just on speculation of Covid-19 approvals and other indications in the pipeline that have the exact same method of action like NASH and maybe 22 different Cancers.
That article isn’t exactly about Cytodyn but we were mentioned as a Possible therapy for NASH. Remember when Nader said our animal testing were twice as good as another company’s animal trial and they received a 100 million licensing deal on a phase 1/2 animal trial. We somehow missed our possible licensing deal on NASH. But we took a different path lately for Covid-19.
After reading that alpha article. Just look at the numbers that do have NAFLD. It's 1 billion people. For Nash numbers...Take 2% of that 1 billion = 20 million x $60,000 annual therapy= 1.2 trillion dollars which would have a stock price of around $1,500/share approx. that’s only at 2% and that is even a conservative number when the estimate is between 3-12% have Nash of that one billion NAFLD. So it could be even more or still have some market share if other drugs prove to be good also. Will there ever be a ceiling on stock price for this drug???
Then look at the Tedx and the Beckham videos this past week for more second party scientific information being released. Also, Ted talks has their own cable channel in some countries. Doesn’t seem to have a ton of views in YouTube yet but I know Canada has Ted talks on their cable tv. It would appear that word is getting out without Cytodyn having to advertise. I do miss a weekly conference call. I hope we still have some kind of communication with Nader weekly or monthly. Being in the loop is a good thing.
We are going to continue to climb In SP just on speculation of Covid-19 approvals and other indications in the pipeline that have the exact same method of action like NASH and maybe 22 different Cancers.
(5)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼